论文信息 - Interchangeability Problems of Drugs with Narrow Therapeutic Indices - 字舞流文

Interchangeability Problems of Drugs with Narrow Therapeutic Indices

Yu. V. Olefir | I. I. Snegireva | R. Alyautdin | B. Romanov | K. Zatolochina | V. Polivanov | E. Pasternak

[1] V. A. Merkulov,et al. Analysis of Factors Influencing the Interchangeability of Antiepileptic Drugs , 2016, Pharmaceutical Chemistry Journal.

[2] E. Tichy,et al. A Multicenter Experience With Generic Tacrolimus Conversion , 2011, Transplantation.

[3] A. Kesselheim. The backlash against bioequivalence and the interchangeability of brand-name and generic drugs , 2011, Canadian Medical Association Journal.

[4] A. Humar,et al. The Impact of Conversion From Prograf to Generic Tacrolimus in Liver and Kidney Transplant Recipients With Stable Graft Function , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5] W. Ageno,et al. Brand Name versus Generic Warfarin: A Systematic Review of the Literature , 2011, Pharmacotherapy.

[6] K. Midha,et al. Bioequivalence; Its History, Practice, and Future , 2009, The AAPS Journal.

[7] J. Helderman,et al. Healthcare costs in renal transplant recipients using branded versus generic ciclosporin , 2010 .

[8] S. Al-suwayeh,et al. Brand and generic medications: Are they interchangeable? , 2008, Annals of Saudi medicine.